Enliven Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Enliven Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2020 to Q2 2024.
  • Enliven Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 1.4K %, a 38.4% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 1.4K -872 -38.4% Jun 30, 2024
Q1 2024 1.6K -335 -17.3% Mar 31, 2024
Q4 2023 1.92K +654 +51.6% Dec 31, 2023
Q3 2023 2.21K +487 +28.2% Sep 30, 2023
Q2 2023 2.27K +739 +48.2% Jun 30, 2023
Q1 2023 1.94K +586 +43.3% Mar 31, 2023
Q4 2022 1.27K -182 -12.5% Dec 31, 2022
Q3 2022 1.73K +384 +28.6% Sep 30, 2022
Q2 2022 1.53K +109 +7.69% Jun 30, 2022
Q1 2022 1.35K -389 -22.3% Mar 31, 2022
Q4 2021 1.45K -473 -24.6% Dec 31, 2021
Q3 2021 1.34K -473 -26.1% Sep 30, 2021
Q2 2021 1.42K Jun 30, 2021
Q1 2021 1.74K Mar 31, 2021
Q4 2020 1.92K Dec 31, 2020
Q3 2020 1.82K Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.